What are the guidelines for storing Fresh Frozen Plasma (FFP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Fresh Frozen Plasma Storage Guidelines

Fresh frozen plasma must be stored frozen at -25°C or below, and once thawed can be stored at 4°C for up to 24 hours for general use, with an extended 5-day storage period specifically for major hemorrhage associated with trauma. 1

Initial Storage Requirements

  • FFP is rapidly frozen to below -25°C to maintain the integrity of labile coagulation factors V and VIII 1
  • The frozen state must be maintained at -18°C or colder until the time of use 2
  • This freezing process preserves all factors of the soluble coagulation system 1

Thawing Methods

FFP can be thawed using three acceptable methods 1:

  • Dry oven: 10 minutes
  • Microwave: 2-3 minutes
  • Water bath: 20 minutes at 37°C

Research suggests thawing at 45°C reduces thawing time by 17% without affecting coagulation factor activity, though 37°C remains the standard guideline recommendation 3

Post-Thaw Storage: Critical Time Limits

Standard Storage (General Use)

  • Thawed FFP can be stored at 4°C for up to 24 hours 1, 4
  • Once removed from refrigeration, FFP must be used within 30 minutes 1
  • Never refreeze thawed FFP 1

Extended Storage (Trauma-Specific)

  • For major hemorrhage associated with trauma, storage time has been extended to 5 days at 4°C 1
  • This extended storage maintains adequate coagulation factor levels above minimum release criteria 2

Coagulation Factor Stability During Storage

The evidence demonstrates differential stability of clotting factors during refrigerated storage:

  • Factor II and fibrinogen: Highly stable, with only 5% and 1% reduction respectively at 5 days 2
  • Factor VIII: Significant decline of approximately 60% by day 5, though still above minimum therapeutic levels 2
  • Factor V: Remains within normal range through 10 days of storage 3
  • Factor VII: Stable or may increase during storage 5

Clinical caveat: While Factor VIII declines substantially, the remaining activity still exceeds minimum release criteria for general hemostatic support, though may be suboptimal for specific factor replacement 2

Storage Temperature Considerations

  • Storage at 4°C is mandatory - room temperature storage is not recommended 5
  • Room temperature storage causes more pronounced decreases in Factor VIII (to 59%) and Factor VII (to 69%), and dramatic reduction in Protein S (to 20%) by day 7 5
  • The 4°C storage temperature maintains better overall coagulation factor stability 5

Blood Group Compatibility Requirements

  • FFP should be ABO-compatible with the recipient 1, 4
  • If blood group is unknown, use group AB FFP as it contains no anti-A or anti-B antibodies 1, 4
  • For group O FFP given to non-group O children, it must be high-titre (HT) negative 1

Volume and Dosing Context

  • Approximate volume per bag is 300 mL 1
  • Recommended therapeutic dose is 15 mL/kg to achieve minimum 30% concentration of plasma factors 1, 4

Critical Safety Points

  • Patient identification must be verified against the bag label before administration 1
  • Every effort must be made to avoid wastage given specific storage constraints 1
  • Male-only plasma is preferentially used in the UK to reduce transfusion-related acute lung injury (TRALI) risk 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.